EP 1596881 B1 20081210 - USE OF HUMAN CHORIONIC GONADOTROPIN IN THE TREATMENT OF SYMPTOMS CAUSED BY ENDOMETRIOSIS
Title (en)
USE OF HUMAN CHORIONIC GONADOTROPIN IN THE TREATMENT OF SYMPTOMS CAUSED BY ENDOMETRIOSIS
Title (de)
VERWENDUNG DES MENSCHLICHEN CHORIONGONADOTROPINS IN DER BEHANDLUNG VON ENDOMETRIOSE-SYMPTOMEN
Title (fr)
UTILISATION DE LA GONADOTROPHINE CHORIONIQUE HUMAINE DANS LE TRAITEMENT DES SYMPTOMES CAUSES PAR L'ENDOMETRIOSE
Publication
Application
Priority
IB 0301066 W 20030207
Abstract (en)
[origin: WO2004069271A1] The human chorionic gonadotropin is found to be a new, efficient agent for the treatment of symptoms like chronic pelvic pain, pre-menstrual syndrom, dysmenorrhea, dyspareunia and infertility, caused by endometriosis.
IPC 8 full level
A61K 38/24 (2006.01); A61P 15/02 (2006.01); A61P 15/08 (2006.01)
CPC (source: EP US)
A61K 38/24 (2013.01 - EP US); A61P 15/02 (2017.12 - EP); A61P 15/08 (2017.12 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 2004069271 A1 20040819; AT E416783 T1 20081215; AU 2003212569 A1 20040830; AU 2003212569 A8 20040830; CA 2515297 A1 20040819; DE 60325275 D1 20090122; EP 1596881 A1 20051123; EP 1596881 B1 20081210; US 2006258568 A1 20061116
DOCDB simple family (application)
IB 0301066 W 20030207; AT 03708393 T 20030207; AU 2003212569 A 20030207; CA 2515297 A 20030207; DE 60325275 T 20030207; EP 03708393 A 20030207; US 54485603 A 20030207